Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Fda Inspections
/
AbbVie Inc.

FDA Inspection

•AbbVie Inc.•March 3, 2026

FDA Inspection 1306856 - AbbVie Inc. - March 03, 2026

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns AbbVie Inc., with an inspection on March 3, 2026, issued by the Chicago District Office, covering human drugs.

Company: AbbVie Inc.
Inspection Date: March 3, 2026
Product Type: Human Drugs
Office: Chicago District Office

Open in Dashboard

ID · 93209412-814d-4a62-8488-c4c7f9580e77

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1306856 - AbbVie Inc. - March 03, 2026 | Global Key Solutions